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Abstract
Natural killer (NK) cells are part of the innate immune system and contribute to the eradication of virus infected cells and
tumors. NK cells express inhibitory and activating receptors and their decision to kill a target cell is based on the balance of
signals received through these receptors. MHC class I molecules are recognized by inhibitory receptors, and their presence
during NK cell education influences the responsiveness of peripheral NK cells. We here demonstrate that mice with reduced
MHC class I cell surface expression, due to deficiency of immunoproteasomes, have responsive NK cells in the periphery,
indicating that the lower MHC class I levels do not alter NK cell education. Following adoptive transfer into wild-type (wt)
recipients, immunoproteasome-deficient splenocytes are tolerated in naive but rejected in virus-infected recipients, in an NK
cell dependent fashion. These results indicate that the relatively low MHC class I levels are sufficient to protect these cells
from rejection by wt NK cells, but that this tolerance is broken in infection, inducing an NK cell-dependent rejection of
immunoproteasome-deficient cells.
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Introduction
NK cells are part of the innate immune system and play a role
in the eradication of viruses and tumors. NK cells express a variety
of germ-line encoded inhibitory and activating receptors that
interact with their respective ligands on target cells [1]. Upon
interaction with a potential target cell, the NK cell’s decision
whether to attack this cell is determined by the sum of signals
received through these receptors [2]. MHC class I molecules are
recognized by inhibitory receptors, and therefore, NK cells attack
cells that lack cell surface MHC class I [3]. This ‘missing self’
hypothesis would imply that NK cells from mice that lack MHC
class I expression, like b2m- or TAP-deficient mice, reject their
own cells. This is, however, not the case because developing NK
cells are educated in a MHC class I-dependent process called
‘licensing’ [4] or ‘disarming’ [5], resulting in responsive NK cells in
the periphery. NK cells from mice that lack MHC class I
expression are therefore hyporesponsive [6,7]. The recognition of
MHC class I by murine NK cells is largely dependent on
inhibitory receptors of the Ly49 family [8]. The responsiveness of
peripheral NK cells is thus determined by presence of MHC class I
on the target cell, and by expression of Ly49 on the NK cell. This
responsiveness is tunable like a rheostat, thus, changes in strength
of inhibitory signals during education quantitatively tune NK cell
activity [9–11]. Consequently, mice that express different types
and combinations of MHC class I alleles have functionally
different NK cells as more inhibitory signals during education
result in increasingly responsive NK cells [9,12]. Joncker et al.
showed that NK cell responsiveness correlated with the number of
inhibitory self-MHC class I receptors on NK cells [11].
Previous studies have shown that lymphoid cells of b2m-, TAP-
or tapasin-deficient mice, which fail to express or display low
amounts of MHC class I molecules on their cell surface, are
rejected by wild-type (wt) NK cells [13–15]. MHC class I cell
surface trafficking requires the presence of peptide in the antigen
processing groove. These peptides usually are generated by or
following proteasome-mediated proteolysis. The ability of protea-
somes to degrade proteins and generate high affinity MHC class I-
binding peptides is determined by the identity of the proteasome’
catalytic subunits. In most tissues, proteasome-mediated proteol-
ysis is exerted by three constitutively expressed proteasome
subunits. In contrast, cells exposed to (pro) inflammatory cytokines
as well as lymphoid cells express three inducible proteasome
subunits, named b1i/LMP2, b2i/MECL-1 and b5i/LMP7 that
incorporate into so called immunoproteasomes and enhance the
proteasome-mediated generation of high affinity MHC class I
binding peptides. Conversely, deficiency of these subunits reduces
the abundance of MHC class I molecules on the cell surface
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23769[16–19]. Since the responsiveness of peripheral NK cells is tuned
by strength of inhibitory signals experienced during education, we
here determined whether the relatively low quantities of cell
surface MHC class I molecules in b2i/MECL-1& b5i/LMP7-
deficient mice modify the responsiveness of peripheral NK cell in
these mice. In addition, as different studies already showed that
lymphoid cells lacking one or more immunoproteasome subunits
are rejected upon transfer in infected wt mice [20–22], we
determined whether immunosubunit deficiency render lymphoid
cells into targets for wt NK cells in infected wt recipient mice. Our
data indicate that peripheral NK cells in immunoproteasome-
deficient mice are normally responsive. Transferred immunopro-
teasome-deficient splenocytes were tolerated in wt recipients, but
rejected in an NK cell-mediated fashion following infection of the
recipient mice.
Results
Reduced MHC class I cell surface expression on DCs of
immunosubunit- & RAG1-deficient mice
During development, NK cell education depends on interactions
between MHC class I molecules and NK cell-expressed inhibitory
receptors. It has been shown previously that mice deficient for
immunoproteasomes express reduced levels of cell-surface MHC
class I molecules [16,18,19]. To investigate whether immunopro-
teasomes, by reducing MHC class I expression, alter NK cell
education, we used b5i/LMP7- plus b2i/MECL-1-deficient mice
bred onto a RAG1-deficient background (RAG1
2/2), which have
relatively high numbers of NK cells. Consistent with previous data
in immunocompetent wt and b2i/MECL-1& b5i/LMP7-deficient
mice, amounts of MHC class I H2-K
b molecules expressed on
splenic dendritic cells (DCs) and other lymphoid cells of RAG1
2/2
b2i/MECL-1
2/2 b5i/LMP7
2/2 mice were considerably lower
than those on DCs of RAG1-deficient controls (Figure 1A, B and
data not shown). Infection of mice with Listeria monocytogenes
upregulates MHC class I expression in infected tissue [18,19]. In
line with these findings, treatment of RAG1
2/2 mice with the
immunostimulator poly(I:C) led to upregulation of H2-K
b cell
surface expression on DCs of these mice (Figure 1B and data not
shown). Also DCs in poly(I:C)-treated b2i/MECL-1& b5i/
LMP7&RAG1-deficient mice upregulated MHC class I H-2K
b
expression, but to a lesser extent than DCs in RAG1-deficient mice.
The reduced ability of immunosubunit-deficient DCs to upregulate
MHC class I cell surface expression reflects a defect in the supply of
high affinity peptides available for binding to MHC class I
molecules [19].
Responsiveness of peripheral NK cells in immunosubunit-
deficient mice
The responsiveness of peripheral NK cells is quantitatively
tuned by the number of MHC class I molecules that are present
during NK cell development [9–11]. We therefore assessed the
responsiveness of peripheral NK cells in immunosunit-deficient
mice, which have reduced MHC class I levels. We first measured
some general aspects and consistently found that the numbers of
NK cells in the spleens of RAG1
2/2 b2i/MECL-1
2/2 b5i/
LMP7
2/2 mice were significantly lower than in RAG1
2/2 mice
(Figure 2A). We furthermore analyzed CD27 and CD11b
expression on NK cells from RAG1
2/2 b2i/MECL-1
2/2 b5i/
LMP7
2/2 and RAG1
2/2 mice to define their maturation status.
The most immature NK cells are CD11b
2CD27
2 (R1) and
during maturation they become CD11b
2CD27
+ (R2),
CD11b
+CD27
+ (R3) and finally CD11b
+CD27
2 (R4), respectively
[23,24]. Comparing the two groups of mice, we found that the
expression of these markers were highly comparable (Figure 2B,
C). To assess the responsiveness of NK cells, we stimulated
splenocytes from RAG1
2/2 and RAG1
2/2 b2i/MECL-1
2/2
b5i/LMP7
2/2 mice with plate-bound antibodies against NKp46
and NKG2D and measured CD69 upregulation, the production of
Figure 1. Effect of immunoproteasome-deficiency on constitutive expression and activation-induced upregulation of MHC class I
molecules. Splenocytes of untreated or poly(I:C) treated RAG1
2/2 and RAG1
2/2b2i/MECL-1
2/2b5i/LMP7
2/2 (RAG1
2/2IS
2/2) mice were analyzed for
the expression of H2-K
b on DCs (CD11c
hiCD11b
int). (A) Representative histogram of untreated mice showing H2-K
b expression on DCs. (B) H2-K
b mean
fluorescent intensity (MFI) on DCs of individual mice. Data are representative of three independent experiments, n=4–6 mice per group. Statistical
analysis was performed using a Mann-Whitney U test. *, P,0.05.
doi:10.1371/journal.pone.0023769.g001
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and LAMP-1 were increased on antibody-stimulated NK cells and
there were no significant differences between the two groups of
mice (Figure 2D–H). Furthermore, when IL-2 was added during
incubation, NK cells from RAG1
2/2 and RAG1
2/2 b2i/MECL-
1
2/2 b5i/LMP7
2/2 mice upregulate CD69, IFNc, and LAMP-1
in a similar fashion (Figure 2D–H). Together, these results show
that splenic NK cells from RAG1
2/2 b2i/MECL-1
2/2 b5i/
LMP7
2/2 and RAG1
2/2 mice are similarly responsive.
NK cell-dependent rejection of immunosubunit-deficient
cells in infected recipients
Several groups have previously reported that immunosubunit-
deficient cells are rejected after transfer into infected wt recipients
Figure 2. Immunoproteasome-deficient mice have responsive peripheral NK cells. (A–C) Splenocytes of RAG1
2/2 and RAG1
2/2b2i/MECL-
1
2/2b5i/LMP7
2/2 (RAG1
2/2IS
2/2) mice were analyzed by flow cytometry (A) Frequencies of NK cells (DX5
+NKp46
+) as percentage of total
lymphocytes. (B,C) Expression of CD11b and CD27 on DX5
+NKp46
+ NK cells. (B) Representative FACS plots and (C) graph showing percentages of
subsets for individual mice for the regions indicated in (B). (D–H) Splenocytes of RAG1
2/2 and RAG1
2/2IS
2/2 mice were incubated on plates coated
with anti-NKG2D and anti-NKp46, in the presence or absence of IL-2, or left unstimulated. Frequencies of IFNc
+, LAMP-1
+ NK cells and CD69 mean
fluorescent intensity (MFI) on NK cells were determined by flow cytometry. (D) Representative FACS plots showing IFNc
+ and LAMP-1
+ NK cells. (E–H)
Bars showing the percentages of IFNc
+LAMP-1
+ NK cells (E), IFNc
+ NK cells (F), LAMP-1
+ NK cells (G), and CD69 MFIs on NK cells (H). Results are shown
as mean 6 S.E.M. Data are representative for 2 independent experiments with 6 mice per group. Statistical analysis was performed using Mann-
Whitney U test. *, P,0.05.
doi:10.1371/journal.pone.0023769.g002
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MHC class I molecules on b2i/MECL-1
2/2 b5i/LMP7
2/2 cells
might reduce the strength of inhibitory signals received by NK
cells in infected wt recipients, we decided to investigate whether
NK cells contributed to the observed rejection. Splenocytes of
congenic wt CD45.1
+ and CD45.2
+ b2i/MECL-1
2/2 b5i/
LMP7
2/2 mice were mixed and transferred i.v. into wt
CD45.1.2 recipients that either had been treated with anti-asialo
GM1 to deplete NK cells (Figure 3B) or had been left untreated.
Subsequently, the recipients were infected i.n. with influenza virus
or left uninfected. Eight days later, mice were sacrificed and
percentages of donor-derived B cells were determined by FACS
analysis (Figure 3A). In uninfected recipient mice, the numbers of
recovered immunosubunit-deficient CD45.2 B cells exceeded
those of CD45.1 cells (Figure 3C), which reflected the relatively
high frequencies of B cells in b2i/MECL-1
2/2 b5i/LMP7
2/2
mouse spleens. No significant differences in relative quantities of
b2i/MECL-1
2/2 b5i/LMP7
2/2 B cells were detected between
NK cell depleted and undepleted naı ¨ve mice (Figure 3C)
indicating that b2i/MECL-1
2/2 b5i/LMP7
2/2 B cells were
tolerated by NK cells in naı ¨ve wt recipients. Conversely, after
infection with influenza virus, the relative proportions of recovered
b2i/MECL-1
2/2 b5i/LMP7
2/2 cells were dramatically de-
creased in undepleted compared to NK cell depleted mice
(Figure 3C). Thus, although tolerated by naı ¨ve recipients, a
relatively high proportion of b2i/MECL-1
2/2 b5i/LMP7
2/2
cells is rejected by NK cells in infected wt recipient mice.
Splenocytes from poly(I:C)-treated immunoproteasome-
deficient mice are tolerated by wt NK cells in naı ¨ve mice
Our data thus far showed that immunoproteasome-deficient
splenocytes were rejected by wt NK cells in infected recipients.
This increased sensitivity to NK cell-mediated lysis might result
from inflammation-induced changes of the target cells, from
changes in NK cell sensitivity (i.e. priming; [25]), or from a
combination of the two. To address these possibilities, a mix of
CFSE-labeled splenocytes of untreated b2i/MECL-1& b5i/
LMP7-deficient (CFSE
low) and poly(I:C) treated b2i/MECL-1&
b5i/LMP7-deficient (CFSE
high) mice was transferred into naı ¨ve
untreated and anti-asialo GM1-treated wt recipients. Adoptively
transferred b2i/MECL-1& b5i/LMP7-deficient splenocytes of
naı ¨ve mice are tolerated by NK cells in naı ¨ve wt mice (Figure 3)
Figure 3. Rejection of immunosubunit-deficient cells in influenza virus infected mice. Splenocytes of congenic CD45.1 (wt) and CD45.2
b2i/MECL-1
2/2b5i/LMP7
2/2 (IS
2/2) mice were 1:1 mixed based on total cell numbers, and transferred i.v. into untreated or anti-asialo GM1 treated
CD45.1.2 recipients, that were subsequently infected i.n. with influenza virus or left uninfected. Recipient mice were sacrificed 8 days later and spleens
were analyzed. (A) Representative FACS plots showing gating strategies and percentages of recovered CD45.1
+ (wt) and CD45.2
+ (IS
2/2) cells of
CD19
+ cells in the different groups: uninf – NK (uninfected, anti-asialo GM1 treated), uninf (uninfected, untreated), inf – NK (influenza virus infected,
anti-asialo GM1 treated), inf (influenza virus infected, untreated). (B) Representative FACS plots gated on TCRb
2 cells showing staining for DX5 and
NKp46 on splenocytes from untreated and anti-asialo GM1 treated mice. Cells in the gate are DX5
+NKp46
+ NK cells. (C) Ratio of CD45.2 (IS
2/2)/CD45.1
(wt) calculated by dividing absolute numbers of CD19
+ CD45.2
+ (IS
2/2) cells by absolute numbers of CD19
+ CD45.1
+ (wt) cells. Results are
representative for 2 independent experiments with 5–6 mice per group. Statistical analysis was performed using a Mann-Whitney U test. **, P,0.01.
doi:10.1371/journal.pone.0023769.g003
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transfer, recipient mice were sacrificed and the relative propor-
tions of donor-derived splenocytes were determined by FACS
analysis. Figure 4 shows that the ratios between b2i/MECL-1&
b5i/LMP7-deficient cells of poly(I:C)-treated and untreated mice
were similar both in untreated and NK cell-depleted recipient
mice. These data indicate that adoptively transferred b2i/MECL-
1&b5i/LMP7-deficient cells of poly(I:C)-treated mice are tolerated
by NK cells in naı ¨ve wt recipients.
Discussion
Previous studies have shown that defects in MHC class I antigen
processing that reduce MHC class I cell surface expression, such as
caused by for example a lack of b2m or tapasin, are accompanied
by hyporesponsiveness of peripheral NK cells [6,7]. In the current
study, we show that immunoproteasome-deficient mice, despite
diminished MHC class I cell surface expression, have responsive
peripheral NK cells. We furthermore show that adoptively
transferred immunoproteasome-deficient splenocytes are tolerated
by wt NK cells in naı ¨ve mice, however, are rejected by NK cells in
influenza virus infected mice. These data suggest that decreased
MHC class I surface expression due to a lack of immunoprotea-
some expression, enhances the susceptibility of cells to NK cell
mediated lysis in infected recipients.
We decided to assess the responsiveness of NK cells of
immunoproteasome-deficient mice, since NK cells are educated
in a MHC class I-dependent fashion, and the level of MHC class I
influences the NK cell responsiveness [9–11]. Although immuno-
proteasome-deficient mice have lower MHC class I levels
(Figure 1), they have normal responsive NK cells in the periphery
(Figure 2 D–H). These results seem in contrast with the rheostat
model, which states that the responsiveness of peripheral NK cell is
tuned by the amount of inhibitory signals received during
education. Ho ¨glund’s group studied the quantitative aspect of
NK cell education by using mice that expressed different MHC
class I alleles [9,10] and found a relation between the inhibitory
input during education and NK cell function in the periphery.
Joncker et al. showed that the number of receptors expressed for
self-MHC class I on NK cells correlated with their responsiveness
[11]. However, in a recent paper, Jonsson et al. studied education
of Ly49A
+ NK cells quantitatively by using a group of MHC
congenic mice [26]. These mice expressed different MHC class I
alleles on the same genetic background. By using Ly49A tetramers,
they measured the affinity of these different MHC class I alleles for
Ly49A, and compared this to educational capacity. Although their
results were largely concordant to the rheostat model, these
authors showed that optimal NK cell education already occurred
with moderate-binding MHC class I ligands. Furthermore, H2-D
d
and H2-D
k hemizygous mice, that showed a reduction in MHC
class I levels of roughly 50%, had educated NK cells in the
periphery, supporting a low saturation threshold for NK cell
education. These findings are in agreement with our results in
RAG1
2/2b2i/MECL-1
2/2b5i/LMP7
2/2 mice, where the de-
crease in MHC class I cell surface levels is approximately 50%, in
the absence of immune stimulation (Figure 1).
Since immunoproteasome-deficient mice express lower levels of
MHC class I molecules on the cell surface, we also tested whether
these cells are targets for NK cell-mediated rejection upon
adoptive transfer into wt recipients. We found that immunopro-
teasome-deficient B cells of b2i/MECL-1&b5i/LMP7-deficient
C57BL/6 mice, which displayed an approximately 30% reduction
in MHC class I levels [19], were tolerated by NK cells in wt
C57BL/6 mice. This is in line with a report by Brodin et al.,
showing that cells of different types of MHC class I hemizygous
mice, which have up to 60% reduced MHC class I levels, are
tolerated by wt NK cells [27]. In these studies, NK cell-mediated
rejection occurred only when MHC class I levels dropped below
80% of their original level.
Recent studies suggested that adoptively transferred immuno-
proteasome deficient T cells failed to survive in infected recipients
[20–22]. To test whether NK cells are responsible for this loss, we
adoptively transferred immunoproteasome-deficient splenocytes
into NK cell depleted and untreated recipients, which were
subsequently infected with influenza virus. Although immunopro-
teasome-deficient cells were tolerated in naı ¨ve recipients, our
results show a NK cell-dependent rejection in infected recipients
Figure 4. Adoptively transferred splenocytes of poly(I:C)-treated immunoproteasome-deficient mice are tolerated by NK cells in
naı ¨ve wt recipients. CFSE-labeled splenocytes of untreated b2i/MECL-12/2b5i/LMP72/2 (IS2/2; CFSElow) and of poly(I:C) treated IS2/2
(CFSEhigh) mice were mixed 1:1 and transferred i.v. into untreated or anti-asialo GM1 treated wt recipients. Recipient mice were sacrificed 17 h later
and spleens were analyzed. (A) Representative FACS plots showing gating strategies. (B) Ratios of poly(I:C) treated (CFSEhigh) and untreated
(CFSElow) IS2/2 cells calculated by dividing absolute numbers of B220+CFSEhigh cells by absolute numbers of B220+CFSElow cells. Results
represent one experiment with 6 mice per group.
doi:10.1371/journal.pone.0023769.g004
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who tested different mechanisms for T cell loss, and concluded
that immunoproteasomes were essential for survival and expansion
of T cells in infected mice [22]. In these studies NK cell-mediated
rejection was considered as unlikely, as transferred immunopro-
teasome-deficient CD8 T cells were tolerated by uninfected
recipients, and because also LMP2- and MECL-1- deficient T cells
were lost, although to a lesser extent than LMP7-deficient cells
[22]. From these and our studies, we conclude that the reason for
loss of immunosubunit-deficient cells in infected wt mice is
complex and involves multiple mechanisms, including NK cell
mediated rejection and a survival/expansion disadvantage.
Sun and Lanier have shown that b2m
2/2:wt mixed BM
chimeric mice lose tolerance upon MCMV infection, resulting in
NK cell-mediated rejection of b2m
2/2 cells [28]. This result
resembles our finding, although we detected NK cell-dependent
rejection of an otherwise tolerated cell-population, while b2m
2/2
cells are rejected by NK cells in a naı ¨ve mouse. We postulate that
the rejection of immunoproteasome-deficient cells in infected
recipients is the net result of two events. First, we showed that
upon inflammation, immunoproteasome deficient cells upregu-
lated MHC class I to a lesser extent than wt NK cells (Figure 1).
Since inflammation also causes upregulation of activating ligands
(Raulet et al, 2003), presumably in immunoproteasome-deficient
cells as in wt cells, an altered balance of activating and inhibitory
ligands might account for the NK cell mediated attack of
immunoproteasome-deficient cells in infected wt recipients.
Secondly, infection induces priming in the LN and thereby
renders NK cells fully functional [25]. To study the role of NK cell
priming, we adoptively transferred splenocytes of poly(I:C) treated
immunoproteasome-deficient mice into naı ¨ve wt mice (Figure 4).
Despite a suboptimal, poly(I:C)-induced upregulation of MHC
class I molecules (Figure 1B) in face of a presumably normal
upregulation of activating ligands, these splenocytes were tolerated
by NK cells in recipient mice. We therefore conclude that NK cell
priming in the wt recipient mice is required to enhance NK cell
sensitivity, which then leads to rejection immunoproteasome-
deficient cells, recognized due to a disbalance between activating
(normal) and inhibitory ligands (reduced).
In conclusion, we here have shown that immunoproteasome-
deficient mice, despite a lower abundance of cell surface MHC
class I molecules, have normally responsive NK cells in the
periphery. Lymphoid cells of immunoproteasome-deficient cells
are tolerated by NK cells in naı ¨ve wt mice, but this tolerance is
broken upon infection.
Materials and Methods
Mice, infection and poly(I:C) stimulation
C57BL/6 (B6).SJL (CD45.1), CD45.1.2 (F1 of B66B6.SJL),
RAG-1
2/2 and b5i/LMP7
2/2b2i/MECL-1
2/2 mice [17] were
maintained by in-house breeding under standard conditions and
were used between 7–14 weeks of age. RAG1
2/2 mice were
crossed with b2i/MECL-1&b5i/LMP7 gene-deficient mice to
generate b5i/LMP7&b2i/MECL-1&RAG1 gene-deficient mice.
PSMB8 (ib5/LMP7)-deficiency was detected by PCR, using the
oligonucleotides 59- GGACCAGGACTTTACTACGTAGATG-
39 on PSMB8 or 59-CCGACGGCGAGGATCTCGTCGTGA-39
on the neomycin cassette as forward and the PSMB8-specific
oligonucleotide 59-CTTGTACAGCAGGTCACTGACATCG-39
as reverse primer. To detect PSMB10 (ib2/MECL-1)-deficiency,
the oligonucleotides 59-CAGAGAGAAACACGTGACAGACT-
GG-39 on PSMB10 or 59- CCGACGGCGAGGATCTCGT-
CGTGA-39 on the neomycin cassette were used as forward and
the PSMB10-specific oligonucleotide 59- CAGGACAGGTGT-
GGTTCCAGGAGC-39 as reverse primer. RAG1-deficiency was
verified by flow cytometry, using an anti-TCRb and anti-CD19
antibody. Infection with influenza virus (A/HK/631; H3N2) was
performed i.n. under light isofluorane anesthesia with 10
5 50% egg
infective dose in 30 ml PBS as described [29]. For stimulation in
vivo, mice were injected i.v. with 100 mg poly(I:C) in PBS 24 h
before sacrifice.
Ethics Statement
All animal experiments were carried out in strict accordance
with the Dutch Animal Experimentation Act and EU directives
86/609/CEE and 2010/63/EU related to the protection of
vertebrate animals used for experimental or other scientific
purposes. The experimental protocols were approved by the
Committee on Animal Experiments of the University of Utrecht
(DEC 2010.II.12.216 and 2010.II.08.153) and performed in the
Central Laboratory Animal Research Facility of the University of
Utrecht, which has AAALAC (Association for Assessment and
Accreditation of Laboratory Animal Care) accreditation.
Cell isolation, staining and flow cytometry
Mice were sacrificed by cervical dislocation, spleens were
excised, leukocytes were obtained by pressing through a 70-mM
cell strainer (BD Biosciences), and red blood cells were removed by
ammonium chloride lysis. Staining of surface markers with the
indicated antibodies was performed in the presence of Fc block
(2.4G2) for at least 20 minutes on ice. For intracellular staining,
cells were fixed with 2% paraformaldehyde for 20 minutes at
room temperature, and intracellular staining was performed in the
presence of 0.5% saponine for 1 hour at 4uC. Antibodies were
purchased from eBioscience [anti-CD49b (DX5), -CD27
(LG.7F9), -CD11b (M1/70), -CD11c (N418), -H2-K
b (AF6-
88.5.5.3), -CD19 (MB19-1), -NKp46 (29A1.4), -CD45.2 (104), -
IFNc (XMG1.2), -CD69 (MB19-1)] or from Biolegend [anti-
LAMP-1 (1D4B), -TCRb (H57-597), -CD45.1 (A20)]. Samples
were measured on a FACSCantoII (BD Biosciences) and analyzed
with FlowJo software (Tree Star).
Ex vivo stimulation of NK cells
High protein binding EIA/RIA plates (Costar) were left
uncoated or were O/N coated with anti-NKG2D (10 mg/ml)
and anti-NKp46 (10 mg/ml) in PBS, and approximately 0.5610
6
splenocytes of RAG1
2/2 or of RAG1
2/2b5i/LMP7
2/2b2i/
MECL-1
2/2 mice were incubated on these plates in the presence
or absence of 10 mg/ml IL-2. For CD69 measurements, cells were
incubated for 6 hours, and for LAMP-1 and IFNc measurements,
cells were incubated for 2 hours in the absence of and an
additional 6 hours in the presence of 10 mM monensin and
1,25 mg anti-LAMP-1.
Adoptive transfer
Splenocytes of CD45.1 and b5i/LMP7
2/2b2i/MECL-1
2/2
were mixed and approximately 15610
6 cells were transferred i.v.
into CD45.1.2. recipients that were left untreated, NK cell
depleted, or influenza virus infected as indicated. NK cells were
depleted by i.p. (day 21 and day 4) and i.v. (at the time of adoptive
transfer) administration of 25 ml anti-asialo GM1 antisera (Wako)
in 200 ml in PBS. Recipients were sacrificed 8 days later, and the
recovery of CD45.1 and CD45.2 cells was measured by flow
cytometry as described. To adoptively transfer CFSE-labeled
immunoproteasome-deficient cells, splenocytes of untreated and
poly(I:C) treated b2i/MECL-1
2/2b5i/LMP7
2/2 mice were
NK Cell Rejection of Immunosubunit-Deficient Cells
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23769incubated with 0.4 and 4 mM CFSE (Invitrogen), respectively, for
8 minutes at room temperature. After quenching of CFSE with
FCS, the cells were thoroughly washed with PBS, mixed 1:1 and
approximately 10610
6 cells were transferred i.v. into untreated or
NK cell depleted wt recipients as described. Recipient mice were
sacrificed 17 hours later, and quantities of recovered B220
+ donor
cells in the spleen were determined by FACS analysis.
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